Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
British Journal of Pharmacology|July 30, 2013
Emerging therapeutic aspects in oncologyDavid J MacewanCellular Signalling|March 19, 2002
TNF receptor subtype signalling: differences and cellular consequencesDavid J MacEwanBritish Journal of Pharmacology|May 13, 2015
Epigenetics and pharmacologyBarbara Stefanska, David J MacEwanCancers|November 12, 2013
The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cellsStuart A Rushworth, David J MacewanBlood|January 19, 2008
HO-1 underlies resistance of AML cells to TNF-induced apoptosisStuart A Rushworth, David J MacEwanCellular Signalling|February 13, 2007
TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cellsZhigang Zhou, Michelle C Connell, David J MacEwanBiochemical Pharmacology|November 26, 2020
Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitorsVanessa Marensi, Karen R Keeshan, David J MacEwanJournal of Immunology (Baltimore, Md. : 1950)|June 15, 2011
TNF mediates the sustained activation of Nrf2 in human monocytesStuart A Rushworth, Suharsh Shah, David J MacEwanPageof 5